Stem Cell Transplantation for Hematologic Malignancies

Front Matter....Pages i-x
Front Matter....Pages 1-1
Allogeneic and Autologous Stem Cell Transplantation for Acute Leukemia and Myelodysplasia in the Adult....Pages 3-24
Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia....Pages 25-45
Stem Cell Transplantation for Hodgkin’s and Non-Hodgkin’s Lymphomas....Pages 47-84
Autologous and Allogeneic Transplantation for Multiple Myeloma....Pages 85-97
Hematopoietic Progenitor Cell Transplantation for Breast Cancer....Pages 99-132
Front Matter....Pages 133-133
Pathophysiology of Acute Graft-vs-Host Disease....Pages 135-157
Acute Graft-vs-Host Disease....Pages 159-184
Chronic Graft-vs-Host Disease After Transplantation....Pages 185-200
Immune Reconstitution After Allogeneic Transplantation....Pages 201-236
Infection in the Hematopoietic Stem Cell Transplant Recipient....Pages 237-258
EBV Lymphoproliferative Disease After Transplantation....Pages 259-270
Pathophysiology of Lung Injury After Hematopoietic Stem Cell Transplantation....Pages 271-295
Hepatic Veno-Occlusive Disease....Pages 297-314
Quality-of-Life Issues Posttransplantation....Pages 315-333
Front Matter....Pages 335-335
Stem Cell Sources....Pages 337-356
Allogeneic Unrelated Donor Blood and Marrow Transplantation....Pages 357-371
Haploidentical Stem Cell Transplantation....Pages 373-389
Umbilical Cord Hematopoietic Stem Cell Transplantation....Pages 391-414
Front Matter....Pages 415-415
Tumor Contamination of Stem Cell Products....Pages 417-429
T-Cell Depletion to Prevent Graft-vs-Host Disease....Pages 431-451
Front Matter....Pages 451-451
Donor Lymphocyte Infusions....Pages 453-469
Nonmyeloablative Transplantation....Pages 469-484
Back Matter....Pages 485-486